These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14265931)

  • 1. MATHEMATICAL TREATMENT OF ORAL SUSTAINED RELEASE DRUG FORMULATIONS.
    ROWLAND M; BECKETT AH
    J Pharm Pharmacol; 1964 Dec; 16():SUPPL:156-62T. PubMed ID: 14265931
    [No Abstract]   [Full Text] [Related]  

  • 2. MATHEMATICAL TREATMENT FOR ORAL SUSTAINED RELEASE DRUG FORMULATIONS.
    NELSON E
    J Pharm Pharmacol; 1965 Mar; 17():190. PubMed ID: 14296946
    [No Abstract]   [Full Text] [Related]  

  • 3. Mathematical model of sustained-release preparations and its analysis.
    Thiemer EK; Eriksen SP
    J Pharm Sci; 1966 Nov; 55(11):1249-53. PubMed ID: 5969781
    [No Abstract]   [Full Text] [Related]  

  • 4. A method to optimize the design parameters of sustained release preparations.
    Cadorniga R; Frutos G; Martin PJ
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():385-8. PubMed ID: 1820912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A note on mathematics of oral sustained release products.
    NELSON E
    J Am Pharm Assoc Am Pharm Assoc; 1957 Sep; 46(9):572-3. PubMed ID: 13491455
    [No Abstract]   [Full Text] [Related]  

  • 6. Mathematical models for the release of drugs from matrix tablets.
    Cobby J
    J Biomed Mater Res; 1978 Sep; 12(5):627-34. PubMed ID: 701299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical formulation of sustained-release dosage forms.
    Robinson JR; Eriksen SP
    J Pharm Sci; 1966 Nov; 55(11):1254-63. PubMed ID: 5969782
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydrogels in controlled release formulations: network design and mathematical modeling.
    Lin CC; Metters AT
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1379-408. PubMed ID: 17081649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of sustained tion parenteral emulsions.
    Windheuser JJ; Best ML; Perrin JH
    Bull Parenter Drug Assoc; 1970; 24(6):286-94. PubMed ID: 5495403
    [No Abstract]   [Full Text] [Related]  

  • 10. Modelling drug dissolution from controlled release products using genetic programming.
    Do DQ; Rowe RC; York P
    Int J Pharm; 2008 Mar; 351(1-2):194-200. PubMed ID: 18053658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anomalous diffusion of drug release from a slab matrix: fractional diffusion models.
    Yin C; Li X
    Int J Pharm; 2011 Oct; 418(1):78-87. PubMed ID: 21163340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.
    HIGUCHI T
    J Pharm Sci; 1963 Dec; 52():1145-9. PubMed ID: 14088963
    [No Abstract]   [Full Text] [Related]  

  • 13. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
    Chen SJ; Zhu JB
    Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride.
    Yadav K; Yadav D; Srivastava AK
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1197-206. PubMed ID: 22803761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time- or position-dependent diffusivity as a mechanism for regulating drug release from slab matrix systems: theoretical models.
    Chang RK
    J Pharm Sci; 1986 Jul; 75(7):717-8. PubMed ID: 3761175
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled-release drug delivery systems and sustained preparations].
    Xi NZ
    Yao Xue Xue Bao; 1984 Sep; 19(9):715-9. PubMed ID: 6536186
    [No Abstract]   [Full Text] [Related]  

  • 17. Formulation and experimental evaluation of oral sustained release medication based on the principle of delayed diffusion.
    SIMOONS JR
    Pharm Weekbl; 1963 Mar; 98():225-42. PubMed ID: 13977548
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic principles in the design of immediate-release components in sustained-release formulations with zero-order release characteristics.
    Cheung WK; Silber BM; Yacobi A
    J Pharm Sci; 1991 Feb; 80(2):142-8. PubMed ID: 2051317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release from matrix systems.
    Roseman TJ
    J Pharm Sci; 1975 Oct; 64(10):1731-2. PubMed ID: 1185552
    [No Abstract]   [Full Text] [Related]  

  • 20. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
    Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
    Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.